Bristol-Myers Squibb to Participate in the 37th Annual J.P. Morgan Healthcare Conference

Saturday, January 5, 2019 11:07 am EST

Dateline:

NEW YORK

Public Company Information:

NYSE:
BMY

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that Giovanni Caforio, M.D., chairman and chief executive officer, will join Mark Alles, chairman and chief executive officer of Celgene, for a fireside chat at the 37th Annual J.P. Morgan Healthcare Conference at 7:30 a.m. PT (10:30 a.m. ET) on Monday, January 7, 2019 at the Westin St. Francis in San Francisco.

Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

Contact:

Media:
Carrie Fernandez
609-252-5222
carrie.fernandez@bms.com
or
Laura Hortas
609-240-7025
laura.hortas@bms.com

Investors:
John Elicker
609-252-4611
john.elicker@bms.com
or
Tim Power
609-252-7509
timothy.power@bms.com
or
Bill Szablewski
609-252-5894
william.szablewski@bms.com

$Cashtags

Privacy Policy
Business Wire NewsHQsm